Cannara Biotech's total assets for Q1 2026 were C$173.84M, an increase of 3.08% from the previous quarter. LOVFF total liabilities were C$62.63M for the fiscal quarter, a -5.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.